Last update 21 Nov 2024

FHND1002

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Target-
Mechanism
Neuroprotectants
Therapeutic Areas
Nervous System DiseasesCardiovascular DiseasesEndocrinology and Metabolic Disease+ [1]
Active Indication
Amyotrophic Lateral SclerosisParkinson DiseaseIschemic stroke
Inactive Indication-
Originator Organization
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Active Organization
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
Inactive Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with FHND1002
CTR20241272 / Not yet recruitingPhase 1
一项评价FHND1002颗粒在健康成年志愿者中单/多次给药的安全性、耐受性和药代动力学特征的I期临床研究
[Translation] A Phase I clinical study to evaluate the safety, tolerability and pharmacokinetic characteristics of single/multiple administrations of FHND1002 granules in healthy adult volunteers
100 Clinical Results associated with FHND1002
Login to view more data
100 Translational Medicine associated with FHND1002
Login to view more data
100 Patents (Medical) associated with FHND1002
Login to view more data
100 Deals associated with FHND1002
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Amyotrophic Lateral SclerosisPhase 1
CN
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
12 Apr 2024
Parkinson DiseaseIND Approval
CN
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
22 Mar 2024
Ischemic strokeIND Approval
CN
Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd.
27 Dec 2023
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free